139 related articles for article (PubMed ID: 22858571)
41. Lack of association between the G-2548A polymorphism of the leptin gene and psoriasis in a Turkish population.
Kara N; Aydin F; Senturk N; Gunes S; Canturk MT; Bagci H; Bek Y; Turanli AY
Int J Dermatol; 2007 Dec; 46(12):1271-4. PubMed ID: 18173522
[TBL] [Abstract][Full Text] [Related]
42. Polymorphisms within the tumor necrosis factor-alpha promoter region in patients with HLA-B27-associated uveitis: association with susceptibility and clinical manifestations.
El-Shabrawi Y; Wegscheider BJ; Weger M; Renner W; Posch U; Ulrich S; Ardjomand N; Hermann J
Ophthalmology; 2006 Apr; 113(4):695-700. PubMed ID: 16581430
[TBL] [Abstract][Full Text] [Related]
43. Association of heparanase gene (HPSE-1) single nucleotide polymorphisms with gastric cancer.
Yue Z; Song Y; Wang Z; Luo Y; Jiang L; Xing L; Xu H; Zhang X
J Surg Oncol; 2010 Jul; 102(1):68-72. PubMed ID: 20578081
[TBL] [Abstract][Full Text] [Related]
44. Interleukin-18 promoter polymorphism is associated with lung cancer: a case-control study.
Farjadfar A; Mojtahedi Z; Ghayumi MA; Erfani N; Haghshenas MR; Ghaderi A
Acta Oncol; 2009; 48(7):971-6. PubMed ID: 19642044
[TBL] [Abstract][Full Text] [Related]
45. The association between proinflammatory cytokine polymorphisms and cerebral palsy in very preterm infants.
Kapitanović Vidak H; Catela Ivković T; Jokić M; Spaventi R; Kapitanović S
Cytokine; 2012 Apr; 58(1):57-64. PubMed ID: 22266275
[TBL] [Abstract][Full Text] [Related]
46. [Correlations of polymorphisms in matrix metalloproteinase-3 and -7 promoters to susceptibility to brain astrocytoma].
Lu ZQ; Wang YM; Cao YY; Zhang QJ; Zhang XH; Li YH; Wang HS; Xie HL; Jiao BH; Zhang JH
Ai Zheng; 2007 May; 26(5):463-8. PubMed ID: 17672933
[TBL] [Abstract][Full Text] [Related]
47. CTLA-4 gene polymorphism of exon 1(+49 A/G) in Turkish systemic lupus erythematosus patients.
Ulker M; Yazisiz V; Sallakci N; Avci AB; Sanlioglu S; Yegin O; Terzioglu E
Int J Immunogenet; 2009 Aug; 36(4):245-50. PubMed ID: 19602000
[TBL] [Abstract][Full Text] [Related]
48. Survivin SNP-carcinogen interactions in oral cancer.
Weng CJ; Hsieh YH; Chen MK; Tsai CM; Lin CW; Yang SF
J Dent Res; 2012 Apr; 91(4):358-63. PubMed ID: 22318371
[TBL] [Abstract][Full Text] [Related]
49. Functional promoter -31G>C variant in survivin gene is associated with risk and progression of renal cell cancer in a Chinese population.
Qin C; Cao Q; Li P; Ju X; Wang M; Chen J; Wu Y; Meng X; Zhu J; Zhang Z; Lu Q; Yin C
PLoS One; 2012; 7(1):e28829. PubMed ID: 22295057
[TBL] [Abstract][Full Text] [Related]
50. RECK Gene Polymorphism is Associated with Susceptibility and Prognosis of Wilms' Tumor in Chinese Children.
Yu Y; Hu Y; Li K; Chen Z; Zhang H; Zhang L
Med Sci Monit; 2015 Jul; 21():1928-33. PubMed ID: 26141647
[TBL] [Abstract][Full Text] [Related]
51. Role of the Functional Polymorphism of Survivin Gene (-31G/C) and Risk of Breast Cancer in a North Indian Population.
Rasool I; Afroze D; Wani KA; Yousuf A; Bhat IA; Rah B; Nazir SU; Hussain S; Dubey S
Clin Breast Cancer; 2018 Aug; 18(4):e671-e676. PubMed ID: 29233639
[TBL] [Abstract][Full Text] [Related]
52. Correlation between survivin genetic polymorphisms and lung cancer susceptibility.
Guo G; Zhang Q; Yu Z; Li J; Ding Z; Li J; Tan W
Int J Clin Exp Pathol; 2015; 8(6):7426-30. PubMed ID: 26261647
[TBL] [Abstract][Full Text] [Related]
53. Epistatic interaction between adiponectin and survivin gene polymorphisms in endometrial carcinoma.
Aminimoghaddam S; Shahrabi-Farahani M; Mohajeri-Tehrani M; Amiri P; Fereidooni F; Larijani B; Shafiee G; Amoli MM
Pathol Res Pract; 2015 Apr; 211(4):293-7. PubMed ID: 25613698
[TBL] [Abstract][Full Text] [Related]
54. Association of survivin promoter polymorphisms with inflammatory bowel disease and response to antitumor necrosis factor therapy.
Rapti E; Gazouli M; Legaki E; Karamanolis G; Thomas D; Marinos E; Papaconstantinou I
Genet Test Mol Biomarkers; 2015 Jun; 19(6):339-43. PubMed ID: 25918954
[TBL] [Abstract][Full Text] [Related]
55. Association of TP53 polymorphisms on the risk of Wilms tumor.
Andrade RC; Cardoso LC; Ferman SE; Faria PS; Seuánez HN; Achatz MI; Vargas FR
Pediatr Blood Cancer; 2014 Mar; 61(3):436-41. PubMed ID: 24038938
[TBL] [Abstract][Full Text] [Related]
56. SPP1 gene polymorphisms associated with nephrolithiasis in Turkish pediatric patients.
Tekin G; Ertan P; Horasan G; Berdeli A
Urol J; 2012; 9(4):640-7. PubMed ID: 23235966
[TBL] [Abstract][Full Text] [Related]
57. A polymorphism in the promoter region of the survivin gene is related to hemorrhagic transformation in patients with acute ischemic stroke.
Mallolas J; Rodríguez R; Gubern C; Camós S; Serena J; Castellanos M
Neuromolecular Med; 2014 Dec; 16(4):856-61. PubMed ID: 25344020
[TBL] [Abstract][Full Text] [Related]
58. Investigation of
Kafadar D; Yaylim I; Kafadar AM; Cacina C; Ergen A; Kaynar MY; Isbir T
Anticancer Res; 2018 Oct; 38(10):5991-5998. PubMed ID: 30275230
[TBL] [Abstract][Full Text] [Related]
59. BARD1 Gene Polymorphisms Confer Nephroblastoma Susceptibility.
Fu W; Zhu J; Xiong SW; Jia W; Zhao Z; Zhu SB; Hu JH; Wang FH; Xia H; He J; Liu GC
EBioMedicine; 2017 Feb; 16():101-105. PubMed ID: 28161399
[TBL] [Abstract][Full Text] [Related]
60. Survivin promoter polymorphisms and autoantibodies in endometriosis.
Lamp M; Saare M; Kadastik Ü; Karro H; Salumets A; Uibo R; Peters M
J Reprod Immunol; 2012 Dec; 96(1-2):95-100. PubMed ID: 23131769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
